Operating Lease, Right-of-Use Asset of PSYCHEMEDICS CORP from 01 Jan 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
PSYCHEMEDICS CORP quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 31 Dec 2024.
  • PSYCHEMEDICS CORP Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $844,000, a 54% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

PSYCHEMEDICS CORP Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $844,000 -$984,000 -54% 31 Dec 2024 10-K 24 Mar 2025 2024 FY
Q3 2024 $959,000 -$1,107,000 -54% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $1,066,000 -$1,234,000 -54% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $1,598,000 -$934,000 -37% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $1,828,000 -$853,000 -32% 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 $2,066,000 -$846,000 -29% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $2,300,000 -$842,000 -27% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $2,532,000 -$788,000 -24% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $2,681,000 -$871,000 -25% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $2,912,000 -$870,000 -23% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $3,142,000 -$867,000 -22% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 $3,320,000 -$935,000 -22% 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 $3,552,000 -$734,000 -17% 31 Dec 2021 10-K 27 Mar 2023 2022 FY
Q3 2021 $3,782,000 -$726,000 -16% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $4,009,000 -$719,000 -15% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $4,255,000 +$1,644,000 +63% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $4,286,000 +$1,411,000 +49% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 $4,508,000 +$1,294,000 +40% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $4,728,000 +$3,312,000 +234% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 $2,611,000 +$1,012,000 +63% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 $2,875,000 +$1,275,000 +80% 31 Dec 2019 10-K 26 Mar 2021 2020 FY
Q3 2019 $3,214,000 30 Sep 2019 10-Q 24 Oct 2019 2019 Q3
Q2 2019 $1,416,000 30 Jun 2019 10-Q 24 Jul 2019 2019 Q2
Q1 2019 $1,599,000 31 Mar 2019 10-Q 25 Apr 2019 2019 Q1
Q4 2018 $1,600,000 01 Jan 2019 10-Q 25 Apr 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.